Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT02625870

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02625870
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02625870. Randomized; double masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
Acronym
OMEELVHT
Condition
Hypertriglyceridemia
Intervention (Drug)
Omega-3-Acid Ethyl Esters 90 Soft Capsules
Intervention (Drug)
Corn Oil
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02625870
Content hash
416504c7a2d325287b3c52468443fd5290c25c73635c568ac93bdf5bc0337a4c